Search results
FDA Approves Rystiggo: The Only Treatment for Two Most Common Subtypes of Generalized Myasthenia...
Benzinga via Yahoo Finance· 11 months agoThe FDA approved UCB SA's (OTC: UCBJF) (OTC: UCBJY) Rystiggo (rozanolixizumab-noli) for generalized...
What Is Myasthenia Gravis?
Health via Yahoo News· 11 months agoMyasthenia gravis (MG) is a chronic (long-term) autoimmune disorder that causes muscle weakness and fatigue. When a person has an autoimmune disorder,...
Europe's CHMP Recommends Approving AstraZeneca's Asthma, Neuromuscular Disorder Treatments
Benzinga via Yahoo Finance· 2 years agoThe European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has...
AstraZeneca's (AZN) Ultomiris Gets EC Nod for New Indication
Zacks via Yahoo Finance· 2 years agoAstraZeneca AZN announced that the European Commission has granted marketing approval to long-acting...
Argenx's Vyvgart Hytrulo Becomes First FDA Approved Subcutaneous Option For Generalized Myasthenia...
Benzinga via Yahoo Finance· 11 months agoThe FDA has approved Argenx SE's (NASDAQ: ARGX) Vyvgart Hytrulo (efgartigimod alfa and...
Argenx's Drug Scores European Approval For Muscular Fatigue Disorder
Benzinga via Yahoo Finance· 2 years agoThe European Commission has approved Argenx SE's (NASDAQ: ARGX) Vyvgart (efgartigimod alfa-fcab) as...
Mysteries of the poisonous amphibians
Knowable en Español via Yahoo News· 1 year agoFrom the brightly colored poison frogs of South America to the prehistoric-looking newts of the Western US, the world is filled with beautiful, deadly...
Rhodiola: Everything You Need to Know
Verywell Health via Yahoo News· 9 months agoKnown to help support mood, stress, and stamina.Medically reviewed by Melissa Nieves, LND Rhodiola (Rhodiola rosea) is a plant widely distributed at high...
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoVanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2022 Earnings Call Transcript February 8, 2023 Operator:...
Argenx Is Tracking Well Above the Industry
GuruFocus.com via Yahoo Finance· 3 months agoArgenx SE (NASDAQ:ARGX) is a fast-growing pharmaceutical company focused on developing next-generation medicines to combat various autoimmune diseases....
